TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 61 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,995,224 | +3618.9% | 265,055 | +2763.9% | 0.00% | – |
| Q4 2022 | $268,765 | -4.0% | 9,255 | -0.7% | 0.00% | – |
| Q3 2022 | $280,000 | -20.7% | 9,320 | -4.4% | 0.00% | – |
| Q2 2022 | $353,000 | -96.5% | 9,752 | -95.8% | 0.00% | -100.0% |
| Q1 2022 | $10,014,000 | -27.2% | 231,498 | -15.7% | 0.00% | 0.0% |
| Q4 2021 | $13,763,000 | -16.5% | 274,654 | +6.0% | 0.00% | -25.0% |
| Q3 2021 | $16,484,000 | +27.9% | 259,059 | +44.7% | 0.00% | +33.3% |
| Q2 2021 | $12,886,000 | +8.0% | 179,076 | +10.7% | 0.00% | 0.0% |
| Q1 2021 | $11,933,000 | +6.8% | 161,797 | +6.3% | 0.00% | 0.0% |
| Q4 2020 | $11,177,000 | +20.8% | 152,239 | -9.7% | 0.00% | 0.0% |
| Q3 2020 | $9,250,000 | -9.8% | 168,650 | +9.3% | 0.00% | -25.0% |
| Q2 2020 | $10,258,000 | +9.8% | 154,269 | +1.1% | 0.00% | 0.0% |
| Q1 2020 | $9,340,000 | -43.1% | 152,613 | -18.3% | 0.00% | -20.0% |
| Q4 2019 | $16,424,000 | +53.5% | 186,788 | +31.7% | 0.01% | +66.7% |
| Q3 2019 | $10,698,000 | -3.6% | 141,786 | +9.2% | 0.00% | 0.0% |
| Q2 2019 | $11,093,000 | -38.0% | 129,865 | -21.5% | 0.00% | -50.0% |
| Q1 2019 | $17,888,000 | +5.3% | 165,488 | -17.5% | 0.01% | -14.3% |
| Q4 2018 | $16,982,000 | -9.7% | 200,624 | +4.9% | 0.01% | +16.7% |
| Q3 2018 | $18,797,000 | -0.5% | 191,216 | +17.1% | 0.01% | 0.0% |
| Q2 2018 | $18,895,000 | +8.1% | 163,324 | -7.7% | 0.01% | -14.3% |
| Q1 2018 | $17,478,000 | -4.3% | 177,008 | +1.5% | 0.01% | 0.0% |
| Q4 2017 | $18,261,000 | +684.1% | 174,397 | +744.3% | 0.01% | +600.0% |
| Q3 2017 | $2,329,000 | +30.4% | 20,656 | +29.6% | 0.00% | 0.0% |
| Q2 2017 | $1,786,000 | +23.9% | 15,939 | +28.9% | 0.00% | – |
| Q1 2017 | $1,442,000 | +117.5% | 12,369 | +96.6% | 0.00% | – |
| Q4 2016 | $663,000 | -5.8% | 6,290 | -1.3% | 0.00% | – |
| Q3 2016 | $704,000 | -5.5% | 6,374 | +24.6% | 0.00% | – |
| Q2 2016 | $745,000 | -1.3% | 5,115 | -2.9% | 0.00% | – |
| Q1 2016 | $755,000 | +20.8% | 5,270 | +25.0% | 0.00% | – |
| Q4 2014 | $625,000 | +2.8% | 4,217 | +6.7% | 0.00% | – |
| Q3 2014 | $608,000 | +13.4% | 3,951 | +3.3% | 0.00% | – |
| Q2 2014 | $536,000 | +27.6% | 3,825 | +1.2% | 0.00% | – |
| Q1 2014 | $420,000 | – | 3,780 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL MANAGEMENT LP | 582,409 | $90,011,000 | 60.33% |
| GUARDIAN POINT CAPITAL, LP | 70,000 | $10,819,000 | 10.19% |
| Think Investments LP | 186,373 | $28,804,000 | 8.16% |
| Greywolf Capital Management LP | 277,936 | $42,955,000 | 7.45% |
| Valentine Capital Asset Management, Inc. | 28,431 | $4,394,000 | 4.91% |
| FORT, L.P. | 63,675 | $9,841,000 | 4.69% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 527,266 | $81,489,000 | 3.63% |
| RPG Investment Advisory, LLC | 60,910 | $9,413,000 | 3.52% |
| Kerrisdale Advisers, LLC | 81,996 | $12,672,000 | 3.24% |
| Strategic Global Advisors, LLC | 48,154 | $7,442,000 | 3.17% |